Corey Michael Watton

CIK: 0001975404

Transaction Breakdown

Open Market Buys (P)2 (33.3%)

High conviction signal

Open Market Sales (S)1 (16.7%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ZVRA

ZEVRA THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

ZVRA
ZEVRA THERAPEUTICS, INC.
Aug 10, 2026
Exercise(M)
Direct
12.3K shares at avg. $4.97$61K
ZVRA
ZEVRA THERAPEUTICS, INC.
Aug 10, 2026
Sale(S)
Direct
12.3K shares at avg. $11.25$138K
ZVRA
ZEVRA THERAPEUTICS, INC.
Jun 4, 2026
Award(A)
Stock Option (right to buy)
Direct
30K shares-
ZVRA
ZEVRA THERAPEUTICS, INC.
May 29, 2025
Award(A)
Stock Option (right to buy)
Direct
30K shares-
ZVRA
ZEVRA THERAPEUTICS, INC.
Mar 28, 2025
Purchase(P)
Direct
300 shares at avg. $7.84$2K
ZVRA
ZEVRA THERAPEUTICS, INC.
Oct 11, 2024
Purchase(P)
Direct
500 shares at avg. $7.92$4K

		Type	Shares	Price		Ownership
Aug 10, 2026	ZVRA ZEVRA THERAPEUTICS, INC.	Exercise(M)	12,300	$4.97	$61,131	Direct
Aug 10, 2026	ZVRA ZEVRA THERAPEUTICS, INC.	Sale(S)	12,300	$11.25	$138,377	Direct
Jun 4, 2026	ZVRA ZEVRA THERAPEUTICS, INC.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
May 29, 2025	ZVRA ZEVRA THERAPEUTICS, INC.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Mar 28, 2025	ZVRA ZEVRA THERAPEUTICS, INC.	Purchase(P)	300	$7.84	$2,352	Direct
Oct 11, 2024	ZVRA ZEVRA THERAPEUTICS, INC.	Purchase(P)	500	$7.92	$3,958	Direct

1-6 of 6 transactions

About Watton Corey Michael

Watton Corey Michael (SEC CIK 0001975404) files insider reports with the SEC as Director of ZEVRA THERAPEUTICS, INC. (ZVRA).

Signal8 holds 5 ownership filings by Watton Corey Michael, all Form 4s, filed between Oct 16, 2024 and Aug 12, 2026. Those filings report 6 transactions, from Oct 11, 2024 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Watton Corey Michael's filings is in BOSTON, MA.

Recent filings by Watton Corey Michael

Aug 10, 2026: Option exercise of ZVRA shares (Form 4, code M).
Aug 10, 2026: Open-market sale of ZVRA shares (Form 4, code S).
Jun 4, 2026: Grant or award of ZVRA derivative securities (Form 4, code A).
May 29, 2025: Grant or award of ZVRA derivative securities (Form 4, code A).
Mar 28, 2025: Open-market purchase of ZVRA shares (Form 4, code P).

Other insiders filing for ZEVRA THERAPEUTICS, INC. (ZVRA)

McFarlane Neil F., President and CEO
Thompson Rahsaan, Chief Legal & Compliance
FAVORITO TAMARA A, Director
Secor Alicia, Director
Calder Douglas W, Director
Anderson Thomas, Director

How to read Form 4 transaction codes